OR WAIT null SECS
According to the company, its partnership will educate the gaming community on common dry eye symptoms and introduce over-the-counter options like its Systane brand of eye drops.
Alcon is kicking off a partnership with Complexity Gaming that will designate Alcon’s Systane lubricant eye drops as the Official Eye Care Partner of Complexity Gaming.
Dry eye symptoms are affecting people due to increased time in front of screens.¹ According to Alcon, its family of dry eye relief products can be used to temporarily relieve burning and irritation2 due to dryness of the eye that may be exacerbated by prolonged screen time.3
For esports athletes, gamers, and others living with dry eye symptoms, Systane products can help relieve dry eye symptoms such as burning and irritated eyes.3
“Proper eye care is an essential part of our ongoing commitment to improve the holistic health and wellness of esports athletes,” said Jason Lake, Founder and CEO of Complexity Gaming. “Partnering with Alcon will help to educate our players, content creators, and the community at-large on the importance of ocular health.”
Kicking off this month, the partnership aims to raise awareness of the impact of extended digital device usage on the eyes.
Since professional esports athletes and content creators can spend many hours per day training and streaming, they are particularly predisposed to eye fatigue, which can cause burning, stinging, and more.1,2
While in the heat of competition, healthy and refreshed eyes can mean the difference between winning and losing.
“Alcon is excited to partner with Complexity through this first-of-its kind partnership that we hope will help players understand vision changes they might be having because of dry eye and help them find real relief," said Jeff Huffman, senior director of Dry Eye and Ocular Health Marketing at Alcon, in a news release. "Through this partnership, we are thrilled to introduce a new audience to our family of products which includes the newly launched Systane Hydration Multi-Dose Preservative Free lubricant eye drops at a time when they most need relief from dry eye symptoms and can keep their eyes on the prize.”
By partnering with Alcon, Complexity is building upon its ongoing commitment to professionalize player care in the esports industry.
Complexity provides holistic support and resources for players’ mental and physical well-being through the GameStop Performance Center (GSPC), which is equipped with performance-enhancing tools, recovery amenities, and ample mental health resources.
Complexity Gaming is one of North America’s longest-standing esports organizations, and is led by Founder and CEO Jason Lake.
Complexity’s esports teams have won more than 140 championships in nearly 30 game titles over its 15+ year history.
Dry eye is increasingly becoming an issue for gaming enthusiasts. According to the American Academy of Ophthalmology, whole computer use will not harm the eyes, prolonged use can lead to problems.
When using a computer for long periods of time, the eyes blink less than normal. This makes the eyes dry, which may lead to a feeling of eyestrain or fatigue.
The AAO noted that digital-related eye strain can affect people of all ages, and gaming can be a key factor. Eye drops can be a treatment option.
1. “Alcon Survey Shows More Screen Time Causing Consumer Concern About Eye Health, Increasing Symptoms of Dry Eye” from Alcon Media Release, https://www.alcon.com/media-release/alcon-survey-shows-more-screen-time-causing-consumer-concern.
2. Patel, S., Henderson, R., Bradley, L., Galloway, B., & Hunter, L. (1991). Effect of visual display unit use on blink rate and tear stability. Optometry and vision science: official publication of the American Academy of Optometry, 68(11), 888-892.
3. Craig, J.P., Nelson, J. D., Azar, D. T., Belmonte, C., Bron, A. J., Chauhan, S. K., de Paiva, C. S., Gomes, J., Hammitt, K. M., Jones, L., Nichols, J. J., Nichols, K. K., Novack, G. D., Stapleton, F. J., Willcox, M., Wolffsohn, J. S., & Sullivan, D. A. (2017.) TFOS DEWS II Report Executive Summary. The ocular surface, 15(4), 802-812